The Impact of De-escalation of Antianginal Medications on Health Status After Percutaneous Coronary Intervention.

ABSTRACT:

Background

Antianginal medications (AAMs) can be perceived to be less important after percutaneous coronary intervention (PCI) and may be de-escalated after revascularization. We examined the frequency of AAM de-escalation at discharge post-PCI and its association with follow-up health status.

Methods and results

In a 10-center PCI registry, the Seattle Angina Questionnaire was assessed before and 6 months post-PCI. AAM de-escalation was defined as fewer AAMs at discharge versus admission or >25% absolute dose decrease. Of 2743 PCI patients (70% male), AAM were de-escalated, escalated, and unchanged in 299 (11%), 714 (26%), and 1730 (63%) patients, respectively. Patients whose AAM were de-escalated were more likely to report angina at 6 months, compared with unchanged or esc

SUBMITTER: Qintar M 

PROVIDER: S-EPMC5721850 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature